A Study to Evaluate the Effects of Ibrutinib on Cardiac Repolarization in Healthy Participants
Clinical trial NCT02271438 · COMPLETED
Trial details
- NCT number
- NCT02271438
- Sponsor
- Janssen Research & Development, LLC
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2014-10-01
- Primary completion
- 2015-04-01
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.